Home > Financial Ratios > OXYGENTA PHARMACEUTICAL

OXYGENTA PHARMACEUTICAL
EV/Core EBITDA

    Back to All Ratios
OXYGENTA PHARMACEUTICAL is part of below Screeners ↓
Top Undervalued Small Cap Stocks
COMMUNITY POLL
for OXYGENTA PHARMACEUTICAL
Please provide your vote to see the results

OXYGENTA PHARMACEUTICAL Last 5 Year EV/Core EBITDA History

[Standalone]

Mar2024Mar2023Mar2022Mar2021Mar2020
   EV/Core EBITDA(x) -15.97-16.8858.1714.65-4.72

What is the latest EV/Core EBITDA ratio of OXYGENTA PHARMACEUTICAL ?

The latest EV/Core EBITDA ratio of OXYGENTA PHARMACEUTICAL is -15.97 based on Mar2024 Standalone results.
Year EV/Core EBITDA
Mar2024-15.97
Mar2023-16.88
Mar202258.17
Mar202114.65
Mar2020-4.72

How is EV/Core EBITDA of OXYGENTA PHARMACEUTICAL Trending?

Years EV/Core EBITDA % Change
Mar2024 -15.97
Negative
Mar2023 -16.88
Negative
Mar2022 58.17
297.06
Mar2021 14.65
Positive
Mar2020 -4.72 -

Other Financial Ratios of OXYGENTA PHARMACEUTICAL


Compare EV/Core EBITDA ratio of peers of OXYGENTA PHARMACEUTICAL

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
OXYGENTA PHARMACEUTICAL ₹217.2 Cr -15.8% -17.6% -23.5% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹400,893.0 Cr 1% 4.8% -13.5% Stock Analytics
DIVIS LABORATORIES ₹171,976.0 Cr 11.2% 7.4% 10.5% Stock Analytics
CIPLA ₹126,137.0 Cr 3.2% -0.1% -7.8% Stock Analytics
TORRENT PHARMACEUTICALS ₹119,712.0 Cr 0.3% -1.6% 0.8% Stock Analytics
DR REDDYS LABORATORIES ₹105,562.0 Cr 1.3% -3% -6.5% Stock Analytics


OXYGENTA PHARMACEUTICAL Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
OXYGENTA PHARMACEUTICAL

-15.8%

-17.6%

-23.5%

SENSEX

1.6%

1.7%

1.8%


You may also like the below Video Courses